La Clinica terapeuticaHumansAdalimumabCrohn DiseaseBiosimilar PharmaceuticalsRectal Fistula
Efficacy of Adalimumab Biosimilars in Managing Perianal Fistula in Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.
K M M Abdelrehim, A K E Elganyni, A E E Elagouz, M K E Elganyny, R A A Abdelaal, E F Al Naoufi, H A Maskji, M R Bakry
Published: 202510.7417/CT.2025.5307
Abstract
Background: Perianal fistulas represent a severe complication of Crohn's disease (CD), leading to significant morbidity and a decline in patients' quality of life. Adalimumab, a tumor necrosis factor (TNF) inhibitor, has been widely used for managing…
Preview only. Read the full abstract at the source